,,,,,,,TRY $35
MONEYMADE Talent on loan from God!
Veni, Vidi, Vici
http://investorshub.advfn.com/boards/board.aspx?board_id=15029
http://investorshub.advfn.com/boards/board.aspx?board_id=293
Recent PRTA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2026 01:28:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2026 01:28:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:31:27 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:07:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:20:20 PM
- Prothena Reports First Quarter 2026 Financial Results and Business Highlights • Business Wire • 05/07/2026 08:05:00 PM
- Prothena to Report First Quarter 2026 Financial Results on May 7 • Business Wire • 04/30/2026 08:05:00 PM
- Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy • Business Wire • 04/27/2026 08:05:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 11:21:36 PM
- Prothena Announces Leadership Team Updates • Business Wire • 04/10/2026 08:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/27/2026 08:13:54 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/27/2026 08:03:27 PM
- Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026 • Business Wire • 03/21/2026 08:05:00 PM
- Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy • Business Wire • 03/09/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:51:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:51:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:50:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:50:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 09:45:57 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/27/2026 09:41:52 PM
- Prothena Announces up to $100 Million Share Repurchase Plan • Business Wire • 02/27/2026 09:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2026 09:04:46 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 02/27/2026 09:01:35 PM
